YOUR BUSINESS AUTHORITY
Springfield, MO
Amgen entered a deal to purchase drugmaker Horizon Therapeutics.
The acquisition is valued at more than $26 billion.
Amgen, which makes biotech drugs, would get a treatment for thyroid eye disease through the Horizon deal.
Read more from CNBC.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.